Literature DB >> 23127290

Does maintenance CBT contribute to long-term treatment response of panic disorder with or without agoraphobia? A randomized controlled clinical trial.

Kamila S White1, Laura A Payne, Jack M Gorman, M Katherine Shear, Scott W Woods, John R Saksa, David H Barlow.   

Abstract

OBJECTIVE: We examined the possibility that maintenance cognitive behavior therapy (M-CBT) may improve the likelihood of sustained improvement and reduced relapse in a multi-site randomized controlled clinical trial of patients who met criteria for panic disorder with or without agoraphobia.
METHOD: Participants were all patients (N = 379) who first began an open trial of acute-phase CBT. Patients completing and responding to acute-phase treatment were randomized to receive either 9 monthly sessions of M-CBT (n = 79) or assessment only (n = 78) and were then followed for an additional 12 months without treatment.
RESULTS: M-CBT produced significantly lower relapse rates (5.2%) and reduced work and social impairment compared to the assessment only condition (18.4%) at a 21-month follow-up. Multivariate Cox proportional hazards models showed that residual symptoms of agoraphobia at the end of acute-phase treatment were independently predictive of time to relapse during 21-month follow-up (hazards ratio = 1.15, p < .01).
CONCLUSIONS: M-CBT aimed at reinforcing acute treatment gains to prevent relapse and offset disorder recurrence may improve long-term outcome for panic disorder with and without agoraphobia.

Entities:  

Mesh:

Year:  2012        PMID: 23127290      PMCID: PMC3565038          DOI: 10.1037/a0030666

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  39 in total

1.  Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment.

Authors:  T A Brown; D H Barlow
Journal:  J Consult Clin Psychol       Date:  1995-10

2.  What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?

Authors:  Borwin Bandelow; David S Baldwin; Ornah T Dolberg; Henning Friis Andersen; Dan J Stein
Journal:  J Clin Psychiatry       Date:  2006-09       Impact factor: 4.384

3.  Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation.

Authors:  J Hafner; I Marks
Journal:  Psychol Med       Date:  1976-02       Impact factor: 7.723

4.  Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.

Authors:  M Mavissakalian; J M Perel
Journal:  Arch Gen Psychiatry       Date:  1992-04

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 6.  A modern learning theory perspective on the etiology of panic disorder.

Authors:  M E Bouton; S Mineka; D H Barlow
Journal:  Psychol Rev       Date:  2001-01       Impact factor: 8.934

7.  Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.

Authors:  D H Barlow; J M Gorman; M K Shear; S W Woods
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

8.  Multicenter collaborative panic disorder severity scale.

Authors:  M K Shear; T A Brown; D H Barlow; R Money; D E Sholomskas; S W Woods; J M Gorman; L A Papp
Journal:  Am J Psychiatry       Date:  1997-11       Impact factor: 18.112

9.  Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy.

Authors:  Cindy J Aaronson; M Katherine Shear; Raymond R Goetz; Laura B Allen; David H Barlow; Kamila S White; Susan Ray; Roy Money; John R Saksa; Scott W Woods; Jack M Gorman
Journal:  J Clin Psychiatry       Date:  2008-03       Impact factor: 4.384

10.  Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up.

Authors:  Kimberly A Yonkers; Steven E Bruce; Ingrid R Dyck; Martin B Keller
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

View more
  10 in total

1.  CLINICAL CONSEQUENCES OF THE REVISED DSM-5 DEFINITION OF AGORAPHOBIA IN TREATMENT-SEEKING ANXIOUS YOUTH.

Authors:  Danielle Cornacchio; Tommy Chou; Hayley Sacks; Donna Pincus; Jonathan Comer
Journal:  Depress Anxiety       Date:  2015-04-04       Impact factor: 6.505

2.  Patterns of early change and their relationship to outcome and early treatment termination in patients with panic disorder.

Authors:  Wolfgang Lutz; Stefan G Hofmann; Julian Rubel; James F Boswell; M Katherine Shear; Jack M Gorman; Scott W Woods; David H Barlow
Journal:  J Consult Clin Psychol       Date:  2014-01-20

3.  A preliminary investigation of the long-term outcome of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders.

Authors:  Jacqueline R Bullis; Meghan R Fortune; Todd J Farchione; David H Barlow
Journal:  Compr Psychiatry       Date:  2014-07-22       Impact factor: 3.735

4.  The effects of aggression on symptom severity and treatment response in a trial of cognitive behavioral therapy for panic disorder.

Authors:  Clair Cassiello-Robbins; Laren R Conklin; Ujunwa Anakwenze; Jack M Gorman; Scott W Woods; M Katherine Shear; David H Barlow
Journal:  Compr Psychiatry       Date:  2015-05-01       Impact factor: 3.735

5.  Patient characteristics and variability in adherence and competence in cognitive-behavioral therapy for panic disorder.

Authors:  James F Boswell; Matthew W Gallagher; Shannon E Sauer-Zavala; Jacqueline Bullis; Jack M Gorman; M Katherine Shear; Scott Woods; David H Barlow
Journal:  J Consult Clin Psychol       Date:  2013-01-21

6.  Therapist effects and the outcome-alliance correlation in cognitive behavioral therapy for panic disorder with agoraphobia.

Authors:  Jonathan D Huppert; Yogev Kivity; David H Barlow; Jack M Gorman; M Katherine Shear; Scott W Woods
Journal:  Behav Res Ther       Date:  2013-11-12

7.  Cognitive behavioral therapy for adults with attention-deficit hyperactivity disorder: study protocol for a randomized controlled trial.

Authors:  Fang Huang; Qiujin Qian; Yufeng Wang
Journal:  Trials       Date:  2015-04-14       Impact factor: 2.279

8.  Clinical Practice Guidelines for Cognitive-Behavioral Therapies in Anxiety Disorders and Obsessive-Compulsive and Related Disorders.

Authors:  Y C Janardhan Reddy; Paulomi M Sudhir; M Manjula; Shyam Sundar Arumugham; Janardhanan C Narayanaswamy
Journal:  Indian J Psychiatry       Date:  2020-01-17       Impact factor: 1.759

9.  Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis.

Authors:  Esther Krijnen-de Bruin; Willemijn Scholten; Anna Muntingh; Otto Maarsingh; Berno van Meijel; Annemieke van Straten; Neeltje Batelaan
Journal:  PLoS One       Date:  2022-08-12       Impact factor: 3.752

10.  A Randomized Controlled Trial to Test the Effectiveness of an Immersive 3D Video Game for Anxiety Prevention among Adolescents.

Authors:  Hanneke Scholten; Monique Malmberg; Adam Lobel; Rutger C M E Engels; Isabela Granic
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.